Factors associated with pneumococcal and influenza vaccination in hospitalized people aged ≥65 years.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 20696084)

Published in Epidemiol Infect on August 09, 2010

Authors

X Sintes1, M Nebot, C Izquierdo, L Ruiz, A Domínguez, J M Bayas, I Vera, J Carratalà, D Sousa, Working Group for the Study of Prevention of CAP in the Elderly

Author Affiliations

1: Public Health Agency of Barcelona, Spain.

Articles by these authors

The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26

Cigarette smoking as a risk factor for tuberculosis in young adults: a case-control study. Tuber Lung Dis (1996) 2.62

Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet (2004) 2.33

Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS (1996) 2.14

Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health (2002) 2.13

[Adolescents faced with addictive substances: tobacco, alcohol and noninstitutionalized drugs]. Med Clin (Barc) (1995) 2.05

[Adjuvant chemotherapy in gastric cancer. Experience at the National Institute of Nutrition]. Rev Invest Clin (1992) 2.02

[Evaluation of chromogenic medium CPS ID2 (bioMérieux) in urine cultures]. Enferm Infecc Microbiol Clin (1996) 2.02

[Efficiency of prevaccination screening of anti-HBc in the anti-hepatitis B vaccination programs]. Med Clin (Barc) (1992) 1.94

The distribution of spontaneous mutations on quantitative traits and fitness in Drosophila melanogaster. Genetics (1992) 1.78

An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg (1997) 1.68

Heat requirement for the onset of the Olea europaea L. pollen season in several sites in Andalusia and the effect of the expected future climate change. Int J Biometeorol (2004) 1.54

The imprint of the extragalactic background light in the gamma-ray spectra of blazars. Science (2012) 1.53

Schistosomiasis and the Dogon country (Mali) Am J Trop Med Hyg (1992) 1.46

High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response. J Acquir Immune Defic Syndr (1999) 1.44

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.39

[Inflammatory pseudotumor of the liver presenting as fever of unknown origin]. Med Clin (Barc) (2001) 1.39

[Prevalence of hepatitis C virus antibodies in homosexual men]. Med Clin (Barc) (1994) 1.39

[Speed users (metamphetamines): a return journey between ecstasy (MDMA) and cocaine. Clinical, preventive and health-care questions]. Aten Primaria (2004) 1.39

[Hepatitis E]. Rev Clin Esp (1995) 1.39

[Mortality and hospital stay adjusted for severity as indicators of effectiveness and efficiency of attention to intensive care unit patients]. Med Intensiva (2008) 1.38

Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol (1993) 1.38

[Excess length of stay attributable to nosocomial bacteremia: usefulness of the Hospitalization Appropriateness Protocol]. Med Clin (Barc) (1999) 1.38

Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother (2010) 1.38

[Impact of smoking and alcohol consumption on mortality in the population of Barcelona [Spain]: 1983-1998]. Gac Sanit (2003) 1.38

[Preventive behaviors for the sexual transmission of AIDS, other infections, and pregnancy in high-school students]. Aten Primaria (1999) 1.37

An evaluation of RAPD fragment reproducibility and nature. Mol Ecol (1998) 1.36

Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. AIDS (1999) 1.34

Measurement of triceps skinfold thickness. An investigation of sources of variation. Br J Prev Soc Med (1971) 1.31

Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis (2001) 1.30

Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28

Social inequalities in health related behaviours in Barcelona. J Epidemiol Community Health (2000) 1.27

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis (1998) 1.26

Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clin Microbiol Infect (2012) 1.24

Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia. Virology (1999) 1.23

[Current situation of tuberculosis in Spain. A precarious health care perspective with regard to developed countries]. Med Clin (Barc) (1996) 1.23

Grb2 and its apoptotic isoform Grb3-3 associate with heterogeneous nuclear ribonucleoprotein C, and these interactions are modulated by poly(U) RNA. J Biol Chem (1998) 1.22

Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis (2000) 1.21

Estimation of microsatellite mutation rates in Drosophila melanogaster. Genet Res (2000) 1.20

Altitude and hypertension. Mayo Clin Proc (1977) 1.19

Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother (2000) 1.18

Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis (2000) 1.18

Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz. J Antimicrob Chemother (2008) 1.17

Bradycardia, increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level. Br Heart J (1971) 1.17

Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia. J Clin Microbiol (1999) 1.17

Hepatitis A virus in urban sewage from two Mediterranean countries. Epidemiol Infect (2006) 1.17

Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect (2012) 1.16

Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect (2007) 1.16

Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab. Aliment Pharmacol Ther (2010) 1.14

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS (1998) 1.14

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries. AIDS (1998) 1.14

Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene (2000) 1.14

A nosocomial outbreak of influenza during a period without influenza epidemic activity. Eur Respir J (2003) 1.13

Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine (2000) 1.12

Smoking initiation and cessation by gender and educational level in Catalonia, Spain. Prev Med (2001) 1.12

Seroepidemiology of HIV-1 infection in a Catalonian penitentiary. AIDS (1990) 1.11

Handwashing with soap or alcoholic solutions? A randomized clinical trial of its effectiveness. Am J Infect Control (1999) 1.11

Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen. AIDS (2000) 1.10

Systemic blood pressure in white men born at sea level: changes after long residence at high altitudes. Am J Cardiol (1969) 1.09

A community outbreak of Legionnaires' disease associated with a cooling tower in Vic and Gurb, Catalonia (Spain) in 2005. Eur J Clin Microbiol Infect Dis (2008) 1.08

Orientation of Schizosaccharomyces POMBE Nonliving Cells under Alternating Uniform and Nonuniform Electric Fields. Biophys J (1985) 1.08

Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis (2006) 1.07

Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J (2008) 1.06

Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Eur Respir J (2010) 1.06

Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect (2009) 1.05

Occupation and bladder cancer in Spain: a multi-centre case-control study. Int J Epidemiol (1989) 1.05

Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10. Clin Exp Immunol (2006) 1.05

Dental arch diameters and relationships to oral habits. Angle Orthod (2006) 1.04

Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect (2010) 1.04

Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood (2000) 1.04

Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations. J Virol Methods (1998) 1.03

Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect (2011) 1.03

[Isolation of Leclercia adecarboxylata in a cirrhotic patient]. Enferm Infecc Microbiol Clin (1993) 1.02

Diet and bladder cancer in Spain: a multi-centre case-control study. Int J Cancer (1991) 1.02

Exposure to environmental tobacco smoke at work and at home: a population based survey. Tob Control (2004) 1.02

Longitudinal study of heart disease in a Jamaican rural population. I. Prevalence, with special reference to ECG findings. Bull World Health Organ (1972) 1.01

Germination of Nosema algerae (Microspora) spores: conditional inhibition by D2O, ethanol and Hg2+ suggests dependence of water influxupon membrane hydration and specific transmembrane pathways. J Eukaryot Microbiol (1997) 1.01

Age at starting smoking and number of cigarettes smoked in Catalonia, Spain. Prev Med (1999) 1.00

Dielectrophoretic properties of yeast cells dividing by budding and by transversal fission. Biochim Biophys Acta (1984) 1.00

Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax (2009) 1.00

Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine (2007) 0.99

Statins for community-acquired pneumonia: current state of the science. Eur J Clin Microbiol Infect Dis (2009) 0.99

Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther (2008) 0.99

Mortality attributable to passive smoking in Spain, 2002. Tob Control (2007) 0.99

[Epidemiology of traveler's diarrhea in Spanish tourists travelling in developing countries]. Med Clin (Barc) (1993) 0.98

Italy and Austria before and after study: second-hand smoke exposure in hospitality premises before and after 2 years from the introduction of the Italian smoking ban. Indoor Air (2008) 0.98

Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J (2011) 0.98

Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. J Med Chem (1998) 0.97

Two-stage cultures for the production of astaxanthin from Haematococcus pluvialis. J Biotechnol (2001) 0.97

Disruption of six Saccharomyces cerevisiae genes from chromosome IV and basic phenotypic analysis of deletion mutants. Yeast (1998) 0.97

Dissemination of extended-spectrum beta-lactamase-producing bacteria: the food-borne outbreak lesson. J Antimicrob Chemother (2008) 0.97

Determinants of patient delay among tuberculosis cases in Spain. Eur J Public Health (2004) 0.97

Effective interactions of colloids on nematic films. Eur Phys J E Soft Matter (2009) 0.96